We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$12.3B
AUM Growth
+$227M
Cap. Flow
-$346M
Cap. Flow %
-2.81%
Top 10 Hldgs %
24.75%
Holding
2,377
New
669
Increased
496
Reduced
623
Closed
582

Top Sells

Rank Stock Value
1
NI icon
NiSource
NI
+$77.7M
2
LIN icon
Linde
LIN
+$71M
3
DTE icon
DTE Energy
DTE
+$57.1M
4
FCX icon
Freeport-McMoran
FCX
+$51.7M
5
FDX icon
FedEx
FDX
+$44.9M

Sector Composition

Rank Sector Weight
1 Industrials 11.05%
2 Technology 9.71%
3 Healthcare 9.12%
4 Real Estate 6.85%
5 Utilities 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLUG icon
1526
Plug Power
PLUG
$3.17B
$314K ﹤0.01%
+30,266
New +$275K
SWX icon
1527
Southwest Gas
SWX
$6.45B
$314K ﹤0.01%
+4,934
New +$292K
YEXT icon
1528
Yext
YEXT
$660M
$314K ﹤0.01%
+27,792
New +$264K
NDSN icon
1529
Nordson
NDSN
$18.6B
$312K ﹤0.01%
+1,256
New +$280K
PLMR icon
1530
Palomar
PLMR
$3.47B
$311K ﹤0.01%
+5,356
New +$286K
PWR icon
1531
Quanta Services
PWR
$90.8B
$310K ﹤0.01%
1,579
+300
+23% +$52.4K
COLL icon
1532
Collegium Pharmaceutical
COLL
$852M
$308K ﹤0.01%
14,324
-30,667
-68% -$696K
BUR icon
1533
Burford Capital
BUR
$982M
$306K ﹤0.01%
25,162
+14,769
+142% +$191K
ELAN icon
1534
Elanco Animal Health
ELAN
$12.5B
$306K ﹤0.01%
30,374
-715,371
-96% -$6.64M
KD icon
1535
Kyndryl
KD
$2.84B
$305K ﹤0.01%
+22,947
New +$311K
LH icon
1536
Labcorp
LH
$27.4B
$303K ﹤0.01%
1,460
-22,600
-94% -$4.38M
PDD icon
1537
Pinduoduo
PDD
$125B
$303K ﹤0.01%
4,384
-3,532
-45% -$243K
PRPL icon
1538
Purple Innovation
PRPL
$20.7M
$302K ﹤0.01%
+4,342
New +$313K
KMI icon
1539
Kinder Morgan
KMI
$68.9B
$301K ﹤0.01%
+17,502
New +$297K
TROX icon
1540
Tronox
TROX
$880M
$299K ﹤0.01%
+23,500
New +$295K
JKS
1541
JinkoSolar
JKS
$812M
$298K ﹤0.01%
6,714
+1,887
+39% +$85.4K
RGA icon
1542
Reinsurance Group of America
RGA
$16B
$298K ﹤0.01%
2,152
-40,447
-95% -$5.75M
NWG icon
1543
NatWest
NWG
$74.9B
$297K ﹤0.01%
+48,601
New +$319K
REKR icon
1544
Rekor Systems
REKR
$80.3M
$297K ﹤0.01%
166,874
+16,624
+11% +$23.2K
SMP icon
1545
Standard Motor Products
SMP
$838M
$297K ﹤0.01%
+7,910
New +$289K
MTUS icon
1546
Metallus
MTUS
$800M
$297K ﹤0.01%
+13,790
New +$250K
DOOR
1547
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$297K ﹤0.01%
+2,904
New +$272K
ALKT icon
1548
Alkami Technology
ALKT
$2.15B
$296K ﹤0.01%
+18,070
New +$249K
NTLA icon
1549
Intellia Therapeutics
NTLA
$1.89B
$296K ﹤0.01%
+7,258
New +$294K
EG icon
1550
Everest Group
EG
$14.4B
$295K ﹤0.01%
864
-1,483
-63% -$536K

Similar funds

Michael Gelband's Q2 2023 Portfolio in Review

As of Q2 2023, Michael Gelband held 2,377 positions worth $12.3B, up 1.9% from $12.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Michael Gelband's Q2 2023 filing shows 669 new, 496 increased, 623 reduced and 582 closed positions. Its largest new stake was Pioneer Natural Resource Co.: 364,360 shares worth $75.5M. The largest sale was NiSource, an estimated $77.7M.

By sector, the portfolio is most concentrated in Industrials at 11% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

  • Michael Gelband's largest Q2 2023 buy was Pioneer Natural Resource Co.: 364,360 shares worth $75.5M.
  • Michael Gelband added most to Global Payments in Q2 2023, an estimated $308M increase.
  • Michael Gelband's biggest Q2 2023 reduction was NiSource, cutting an estimated $77.7M.
  • Michael Gelband fully exited L3Harris in Q2 2023, selling an estimated $44.7M.
  • Michael Gelband's ten largest holdings make up 25% of its $12.3B portfolio in Q2 2023.
  • Michael Gelband opened 669 new positions and closed 582 in Q2 2023.
  • Michael Gelband's portfolio value rose 1.9% quarter-over-quarter to $12.3B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.